IP Library › Granted Patent US 11,841,372
Granted Patent B1
US 11,841,372 · App. 17/033,480 · Granted Dec 12, 2023

Techniques for rapid detection and quantitation of volatile organic compounds (VOCs) using breath samples

Inventors: Guido Fridolin Verbeck, IV (Lewisville, TX); John Redmond (Frisco, TX); Tim C. Wing (Frisco, TX); Luke Keiser (Frisco, TX)
Assignees: InspectIR Systems, LLC; University of North Texas
G01N33/948A61B5/082A61B5/097A61B5/4845A61B5/7203A61B5/7246A61B5/7257G01N33/9486
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,841,372
App. No.
17/033,480
Granted
Dec 12, 2023
Kind
B1
Abstract

An exemplary breath analysis system may include a sampling chamber having a molecule collector disposed therein. The molecule collector may be configured such that volatile organic compounds (VOCs) present in a breath sample introduced to the sampling chamber adhere to the molecule collector. A heating element may introduce heat within the sampling chamber, causing release of at least a portion of the VOCs adhered to the molecule collector. An analysis device (e.g., a mass spectrometer or Terahertz (THz) spectrometer) may identify one or more target VOCs from among at least the portion of the VOCs released from the molecule collector and generate an output representative of the identified one or more target VOCs. The output may include information that quantitates a concentration of the one or more target VOCs with respect to a source of the breath sample.

Claims (78)

1. A method for analyzing a breath sample, the method comprising:

receiving, at a sampling chamber, a breath sample via an inlet coupled to the sampling chamber, wherein the sampling chamber comprises a molecule collector disposed within the sampling chamber, and wherein the molecule collector is configured to adhere to volatile organic compounds (VOCs) present in the breath sample;

introducing, via a heating mechanism, heat within the sampling chamber, releasing at least a portion of the VOCs from the molecule collector;

concurrent with introducing heat within the sampling chamber, introducing a vacuum in a spectrometer;

identifying and quantitating, by an analysis device, one or more target VOCs from among the VOCs present in the sampling chamber subsequent to release of at least the portion of the VOCs from the molecule collector, based, at least in part, on correlation of presence and quantity of the one or more target VOCs to a blood level of a foreign substance of interest;

generating, by the analysis device, an output representative of the one or more target VOCs, the output representative of the one or more target VOCs comprises information that quantitates a concentration of the one or more target VOCs with respect to a source of the breath sample and the blood level of the foreign substance of interest; and

concurrent with at least generating the output representative of the one or more target VOCs, cleaning the sampling chamber by:

further heating the sampling chamber; and

evacuating the sampling chamber and the spectrometer using the vacuum.

2. The method of claim 1 , further comprising employing a Fourier Transform to eliminate background noise to:

arrive at the correlation of presence and quantity of the one or more target VOCs to a blood level of the foreign substance of interest to identify and/or quantitate one or more target VOCs from among the VOCs present in the sampling chamber; and/or

generate the output representative of the one or more target VOCs quantitating a concentration of the one or more target VOCs with respect to a source of the breath sample and the blood level of the foreign substance of interest.

3. The method of claim 1 , wherein the one or more target VOCs include:

metabolites, metabolite markers, ketones, aldehydes, or a combination thereof indicative of SARS-CoV-2 and/or Coronavirus Disease 2019 (COVID-19) caused by SARS-CoV-2; and/or

Δ-9-THC, 11-hydroxy-tetrahydrocannabinol (11-OH-THC), carboxy-tetrahydrocannabinol (THCCOOH), THC metabolites, THC metabolites makers, opioids, opioid metabolites, opioid metabolite markers, or a combination thereof.

4. The method of claim 1 , wherein:

identifying and quantitating one or more target VOCs from among the VOCs present in the sampling chamber includes identifying and quantitating one or more target metabolites and/or metabolite markers; and

generating the output representative of the one or more target VOCs representative of the one or more target VOCs comprises information that indicates the presences and/or quantitates a concentration of one or more metabolites and/or metabolite markers.

5. The method of claim 4 , wherein generating the output representative of the one or more target VOCs representative of the one or more target VOCs comprises information that indicates the presences and/or quantitates a concentration of one or more metabolites and/or metabolite markers to establish prior use of the foreign substance of interest.

6. The method of claim 4 wherein generating the output representative of the one or more target VOCs representative of the one or more target VOCs comprises information that indicates the presences and/or quantitates a concentration of one or more metabolites and/or metabolite markers to establish a time frame of prior use of the foreign substance of interest.

7. The method of claim 1 , wherein the molecule collector comprises a Carboxen coated mesh.

8. The method of claim 1 , wherein the spectrometer comprises a mass spectrometer, and the analysis device further comprises a computing device communicatively coupled to the mass spectrometer, and an output device communicatively coupled to the computing device, and wherein the identifying and quantitating the one or more target VOCs and generating the output comprises:

ionizing, by an ionizer of the mass spectrometer, at least the portion of the VOCs released from the molecule collector to produce one or more ionized fragments;

separating, by a mass analyzer of the mass spectrometer, the one or more ionized fragments;

identifying and quantitating, by a detector of the mass spectrometer, the one or more target VOCs based on the separated one or more ionized fragments;

correlating, by the computing device, presence and quantity of the one or more target VOCs to a blood level of the foreign substance of interest; and

generating, by the computing device, an output representative of the one or more target VOCs based on information associated with the one or more target VOCs identified by the detector, with respect to a source of the breath sample and the blood level of the foreign substance of interest; and

displaying the output at the output device.

9. The method of claim 1 , wherein the spectrometer comprises a Terahertz (THz) spectrometer, and wherein the identifying the one or more target VOCs comprises:

emitting, by an excitation source, an excitation signal within the sampling chamber subsequent to the release of at least a portion of the VOCs from the molecule collector; and

identifying, by a detector of the THz spectrometer, the one or more target VOCs based on one or more characteristics associated with excitation of at least the portion of the VOCs released from the molecule collector in response to the excitation signal.

10. The method of claim 9 wherein the one or more characteristics associated with the excitation of at least the portion of the VOCs comprise at least one of an absorbance characteristic and a fluorescent emission characteristic.

11. The system of claim 1 , further comprising a sensor configured to determine whether the breath sample satisfies one or more criterion.

12. A system for analyzing a breath sample, the system comprising:

a sampling chamber;

an inlet coupled to the sampling chamber and configured to receive a breath sample and to provide the breath sample to the sampling chamber;

a molecule collector disposed within the sampling chamber, wherein the molecule collector is configured to adhere to volatile organic compounds (VOCs) present in the breath sample;

a heating mechanism configured to introduce heat within the sampling chamber;

an analysis device comprising a spectrometer, the analysis device configured to:

identify and quantitate one or more target VOCs from among the VOCs present in the sampling chamber subsequent to release of at least a portion of the VOCs from the molecule collector, based, at least in part on correlation of presence and quantity of the one or more target VOCs to a blood level of a foreign substance of interest; and

generate an output representative of the one or more target VOCs comprising information that quantitates a concentration of the one or more target VOCs with respect to a source of the breath sample and the blood level of the foreign substance of interest; and

a vacuum pump configured to introduce a vacuum in the spectrometer concurrent with introducing the heat within the sampling chamber and draw at least a portion of the VOCs released from the molecule collector by the heating of the sampling chamber into the spectrometer; and

the heating mechanism and the vacuum pump further configured to, subsequent to drawing at least a portion of the VOCs released from the molecule collector into the spectrometer, and at least concurrent with generating output representative of the one or more target VOCs, clean the sampling chamber by the heating mechanism further heating the sampling chamber and evacuating the sampling chamber and the spectrometer using the vacuum pump.

13. The system of claim 12 , wherein the molecule collector comprises a Carboxen coated mesh.

14. The system of claim 12 , wherein the one or more target VOCs include:

metabolites, metabolite markers, ketones, aldehydes, or a combination thereof indicative of SARS-CoV-2 and/or Coronavirus Disease 2019 (COVID-19) caused by SARS-CoV-2; and/or

Δ-9-THC, 11-hydroxy-tetrahydrocannabinol (11-OH-THC), carboxy-tetrahydrocannabinol (THCCOOH), THC metabolites, THC metabolites makers, opioids, opioid metabolites, opioid metabolite markers, or a combination thereof.

15. The system of claim 12 , further comprising a computing device communicatively coupled to, or as a part of, the analysis device, the computing device configured to employ a Fourier Transform to eliminate background noise to:

arrive at the correlation of presence and quantity of the one or more target VOCs to a blood level of the foreign substance of interest to identify and/or quantitate one or more target VOCs from among the VOCs present in the sampling chamber; and/or

generate the output representative of the one or more target VOCs quantitating a concentration of the one or more target VOCs with respect to a source of the breath sample and the blood level of the foreign substance of interest.

16. The system of claim 12 , wherein the analysis device is further configured to:

identify and quantitate one or more target VOCs from among the VOCs present in the sampling chamber includes identifying and quantitating one or more target metabolites and/or metabolite markers; and

generate the output representative of the one or more target VOCs representative of the one or more target VOCs comprising information that indicates the presences and/or quantitates a concentration of one or more metabolites and/or metabolite markers.

17. The system of claim 16 , wherein the output representative of the one or more target VOCs representative of the one or more target VOCs comprises information that indicates the presences and/or quantitates a concentration of one or more metabolites and/or metabolite markers to establish prior use of the foreign substance of interest.

18. The system of claim 16 wherein the output representative of the one or more target VOCs representative of the one or more target VOCs comprises information that indicates the presences and/or quantitates a concentration of one or more metabolites and/or metabolite markers to establish a time frame of prior use of the foreign substance of interest.

19. The system of claim 12 , wherein the spectrometer comprises a mass spectrometer, and the analysis device further comprises a computing device communicatively coupled to the mass spectrometer, and an output device communicatively coupled to the computing device, and wherein:

the mass spectrometer includes:

an ionizer configured to ionize at least the portion of the VOCs released from the molecule collector to produce one or more ionized fragments;

a mass analyzer configured to separate the one or more ionized fragments; and

a detector configured to identify and quantitate the one or more target VOCs based on the separated one or more ionized fragments; and

the computing device includes:

one or more processors configured to:

generate the output representative of the one or more target VOCs based on information associated with the one or more target VOCs identified by the detector, with respect to a source of the breath sample and the blood level of the foreign substance of interest; and

display the output at the output device; and

a memory communicatively coupled to the one or more processors.

20. The system of claim 12 , wherein the spectrometer comprises a Terahertz (THz) spectrometer that includes:

an excitation source configured to introduce an excitation signal within the sampling chamber subsequent to the release of at least a portion of the VOCs from the molecule collector; and

a detector configured to identify the one or more target VOCs based on one or more characteristics associated with excitation of at least the portion of the VOCs released from the molecule collector in response to the excitation signal.

21. The system of claim 20 , wherein the excitation source comprises a THz laser, and wherein the one or more characteristics associated with the excitation of at least the portion of the VOCs comprises at least one of an absorbance characteristic and a fluorescent emission characteristic.

22. A non-transitory computer-readable storage medium storing instructions that, when executed by one or more processors, cause the one or more processors to perform operations for analyzing a breath sample, the operations comprising:

activating a heating mechanism configured to introduce heat within a sampling chamber subsequent to a breath sample being provided to the sampling chamber, the sampling chamber comprising a molecule collector disposed within the sampling chamber, and the molecule collector configured to adhere to volatile organic compounds (VOCs) present in the breath sample;

concurrent with heating the sampling chamber, introducing a vacuum in a spectrometer;

identifying and quantitating one or more target VOCs from among the VOCs present in the sampling chamber subsequent to release of at least a portion of the VOCs from the molecule collector, at least the portion of the VOCs released from the molecule collector, based, at least in part, on correlation of presence and quantity of the one or more target VOCs to a blood level of a foreign substance of interest, the one or more target VOCs including metabolites, metabolite markers, ketones, aldehydes, or a combination thereof indicative of SARS-CoV-2 and/or Coronavirus Disease 2019 (COVID-19) caused by SARS-CoV-2 and/or Δ-9-THC, 11-hydroxy-tetrahydrocannabinol (11-OH-THC), carboxy-tetrahydrocannabinol (THC-COOH), THC metabolites, THC metabolite markers, opioids, opioid metabolites, opioid metabolite markers, or a combination thereof;

generating an output representative of the one or more target VOCs, wherein the output representative of the one or more target VOCs comprises information that quantitates a concentration of the one or more target VOCs with respect to a source of the breath sample and the blood level of the foreign substance of interest; and

concurrent with at least generating the output representative of the one or more target VOCs, cleaning the sampling chamber by:

further heating the sampling chamber; and

evacuating the sampling chamber and the spectrometer using the vacuum.

23. The non-transitory computer-readable storage medium of claim 22 , wherein, when executed by one or more processors, the instructions further cause the one or more processors to generate the output representative of the one or more target VOCs representative of the one or more target VOCs comprising information that indicates the presences and/or quantitates a concentration of one or more metabolites and/or metabolite markers to establish a time frame of prior use of the foreign substance of interest.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 25, 2020
From: VERBECK, GUIDO FRIDOLIN, IV, DR.
To: UNIVERSITY OF NORTH TEXAS
Reel/Frame 053893/0310 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 25, 2020
From: REDMOND, JOHN; WING, TIM C.; KEISER, LUKE
To: INSPECTIR SYSTEMS, LLC
Reel/Frame 053893/0342 →
Continuity (3)
Continuation In Part 16715576 · Dec 16, 2019
Continuation PCTIB2019056456 · Jul 29, 2019
Provisional Application 62712941 · Jul 31, 2018
Cited By (2)
US 12,496,010 US 12,721,541